results

Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025

September 09, 2025 11:00 ET  | Source: Chiesi Global Rare Diseases Results presented focus on clinical insights on Fabry disease…

1 month ago

New names set high standards for safety: Togg and firefly shake up the EV market

LEUVEN, BELGIUM – The chances are you won’t have heard of it and will never have seen one of its…

1 month ago

Cango Inc. Reports Second Quarter 2025 Unaudited Financial Results

HONG KONG, Sept. 4, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced its unaudited financial results for the second quarter…

1 month ago

New Fortress Energy Announces Second Quarter 2025 Results

NEW YORK--(BUSINESS WIRE)--New Fortress Energy Inc. (Nasdaq: NFE) (“NFE” or the “Company”) today reported its financial results for the second…

1 month ago

SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%

CHONGQING, China, Sept. 3, 2025 /PRNewswire/ -- On August 29, SERES announced its 2025 mid-year results, reporting strong growth across all…

1 month ago

Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches

ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to…

1 month ago

Kia Announces August 2025 Global Sales Results

August 2025 global sales of 253,950 units, up 0.8% Y/ySales in Korea climbed to 43,501 units, up 7.4% Y/yOutside of…

2 months ago

Anavar For Women And Men: CrazyBulk Launch Anavar Legal Steroid Alternative For Female Read Dosage, Side Effects, (Before and After Cycle results)

New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York CrazyBulk proudly announces the release of…

2 months ago

SANY Reports Strong First Half 2025 Results, Delivering Profitable Growth

Revenue Up 15% to $6.24 Billion; Operating Cash Flow Up 20% to $1.42 Billion SHANGHAI, Aug. 28, 2025 /PRNewswire/ --…

2 months ago

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…

2 months ago